Ubs Group Ag Novavax Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Novavax Inc stock. As of the latest transaction made, Ubs Group Ag holds 525,354 shares of NVAX stock, worth $4.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

525,354

Previous 371,738 41.32%

Holding current value

$4.47 Million

Previous $4.71 Million 40.99%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $1.65 Million - $2.63 Million	153,616 Added 41.32%	525,354 $6.64 Million
Q2 2024 Aug 13, 2024	SELL	$3.89 - $20.97 $2.43 Million - $13.1 Million	-623,752 Reduced 62.66%	371,738 $4.71 Million
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $3.72 Million - $5.96 Million	990,258 Added 18926.95%	995,490 $4.76 Million
Q4 2023 Feb 09, 2024	SELL	$4.8 - $7.67 $16,608 - $26,538	-3,460 Reduced 39.81%	5,232 $25,000
Q3 2023 Nov 09, 2023	SELL	$6.81 - $9.74 $2.71 Million - $3.88 Million	-398,461 Reduced 97.87%	8,692 $62,000
Q2 2023 Aug 11, 2023	SELL	$6.67 - $9.52 $329,651 - $470,506	-49,423 Reduced 10.82%	407,153 $3.03 Million
Q1 2023 May 12, 2023	BUY	$5.76 - $12.48 $2.54 Million - $5.51 Million	441,764 Added 2982.47%	456,576 $3.16 Million
Q4 2022 Feb 08, 2023	SELL	$8.86 - $25.04 $2.06 Million - $5.83 Million	-232,898 Reduced 94.02%	14,812 $152,000
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $1.6 Million - $6.68 Million	87,797 Added 54.9%	247,710 $4.51 Million
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $1.17 Million - $2.42 Million	-32,130 Reduced 16.73%	159,913 $8.22 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $3.02 Million - $6.2 Million	43,369 Added 29.17%	192,043 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $9.73 Million - $15.8 Million	72,337 Added 94.76%	148,674 $21.3 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $5.09 Million - $7.75 Million	28,638 Added 60.04%	76,337 $15.8 Million
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $537,240 - $1.14 Million	-4,440 Reduced 8.52%	47,699 $10.1 Million
Q1 2021 May 12, 2021	BUY	$112.98 - $319.93 $1.34 Million - $3.8 Million	11,890 Added 29.54%	52,139 $9.45 Million
Q4 2020 Feb 11, 2021	SELL	$78.74 - $139.5 $1.75 Million - $3.1 Million	-22,212 Reduced 35.56%	40,249 $4.49 Million
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $3.95 Million - $8.89 Million	49,781 Added 392.59%	62,461 $6.77 Million
Q2 2020 Jul 31, 2020	SELL	$13.86 - $83.61 $324,143 - $1.96 Million	-23,387 Reduced 64.84%	12,680 $1.06 Million
Q1 2020 May 01, 2020	SELL	$3.93 - $16.0 $5,615 - $22,864	-1,429 Reduced 3.81%	36,067 $490,000
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $73,165 - $103,502	19,828 Added 112.23%	37,496 $149,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $58,177 - $113,460	14,472 Added 452.82%	17,668 $89,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $15,756 - $38,991	3,196 New	3,196 $19,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account